Home › Funds › Newtyn Management, LLC › RCKT

Newtyn Management, LLC position in RCKT

ROCKET PHARMACEUTICALS INC · Health Care

Newtyn Management, LLC reported holding 4,000,000 shares of RCKT (ROCKET PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$13.7M, representing 1.71% of its reported portfolio and ranking #21 among its reported holdings. Newtyn Management, LLC has disclosed RCKT holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

Latest position (Q2 2026)4.00M sh
Reported value held$13.68M
Portfolio Weight1.71%
First reportedQ2 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Newtyn Management, LLC's RCKT position evolved

Newtyn Management, LLC first disclosed a stake in RCKT in Q2 2025 at 2,000,000 shares (US$4.9M). The position peaked in Q2 2026 at 4,000,000 shares, worth US$13.7M. Across 5 filings, Newtyn Management, LLC increased the stake 4 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 4,000,000 shares valued at US$13.7M — an increase of 834,100 shares quarter over quarter.. Notable position changes include a 25% increase in Q3 2025 (shares rose 8% over the following quarter), a 26% increase in Q2 2026 (shares fell 23% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 2.00M $4.90M New
Q3 2025 2.50M $8.16M Add
Q4 2025 2.65M $9.30M Add
Q1 2026 3.17M $11.33M Add
Q2 2026 4.00M $13.68M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RCKT and 13F data

RCKT (ROCKET PHARMACEUTICALS INC) is a Health Care company. 18 other funds we track also report a position in RCKT — the largest reported positions include RTW INVESTMENTS, LP (US$60.5M), Maverick Capital (US$13.4M), MAVERICK CAPITAL LTD (US$13.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RCKT

All RCKT fund holders →

FAQ

How long has Newtyn Management, LLC held RCKT?

Newtyn Management, LLC has disclosed RCKT holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

What is Newtyn Management, LLC's current position in RCKT?

As of Q2 2026, Newtyn Management, LLC holds 4.00M shares of RCKT (ROCKET PHARMACEUTICALS INC), valued at $13.68M, representing 1.71% of its reported portfolio and ranking #21.

Has Newtyn Management, LLC been buying or selling RCKT?

In the latest 13F filing (Q2 2026), Newtyn Management, LLC increased its position in RCKT. The position peaked in Q2 2026 at 4.00M shares.

Which other funds hold RCKT?

Other major institutional holders of RCKT include RTW INVESTMENTS, LP, Maverick Capital, MAVERICK CAPITAL LTD, among 18 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.